147 related articles for article (PubMed ID: 1387567)
1. Multiple dopamine receptors and their implications in medicine.
Kebabian JW
Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):514-8. PubMed ID: 1387567
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of dopamine receptors.
Jarvie KR; Caron MG
Adv Neurol; 1993; 60():325-33. PubMed ID: 8380525
[No Abstract] [Full Text] [Related]
4. Dopamine receptor genes: new tools for molecular psychiatry.
Niznik HB; Van Tol HH
J Psychiatry Neurosci; 1992 Oct; 17(4):158-80. PubMed ID: 1450188
[TBL] [Abstract][Full Text] [Related]
5. Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Emre M; Rinne UK; Rascol A; Lees A; Agid Y; Lataste X
Mov Disord; 1992; 7(3):239-43. PubMed ID: 1535688
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptors--the present state of research and perspectives.
Wolfarth S; Ossowska K
Pol J Pharmacol; 1995; 47(3):207-18. PubMed ID: 8714754
[TBL] [Abstract][Full Text] [Related]
7. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
Clark D; White FJ
Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
[TBL] [Abstract][Full Text] [Related]
8. Diversity of dopamine receptors: new molecular and pharmacological developments.
Hartman DS; Lanau F
Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762
[TBL] [Abstract][Full Text] [Related]
9. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
Amenta F; Ricci A; Tayebati SK; Zaccheo D
Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptors and antipsychotic drug response.
Sunahara RK; Seeman P; Van Tol HH; Niznik HB
Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523
[TBL] [Abstract][Full Text] [Related]
11. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Sunahara RK; Guan HC; O'Dowd BF; Seeman P; Laurier LG; Ng G; George SR; Torchia J; Van Tol HH; Niznik HB
Nature; 1991 Apr; 350(6319):614-9. PubMed ID: 1826762
[TBL] [Abstract][Full Text] [Related]
12. Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists.
Williams M; Wright S; Lloyd GK
Trends Pharmacol Sci; 1997 Sep; 18(9):307-10. PubMed ID: 9345846
[No Abstract] [Full Text] [Related]
13. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Sokoloff P; Giros B; Martres MP; Bouthenet ML; Schwartz JC
Nature; 1990 Sep; 347(6289):146-51. PubMed ID: 1975644
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
15. What has been learnt from study of dopamine receptors in Parkinson's disease?
Hurley MJ; Jenner P
Pharmacol Ther; 2006 Sep; 111(3):715-28. PubMed ID: 16458973
[TBL] [Abstract][Full Text] [Related]
16. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
17. Electroretinographic changes in patients with parkinsonism treated with various classes of antiparkinsonian drugs.
Filipová M; Balík J; Filip V; Rodný J; Krejcová H
Act Nerv Super (Praha); 1979 Oct; 21(3):136-8. PubMed ID: 517077
[No Abstract] [Full Text] [Related]
18. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
19. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
20. Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
Metman LV; Blanchet PJ; de Jong D; Mouradian MM; Chase TN
Mov Disord; 1996 May; 11(3):257-60. PubMed ID: 8723141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
